Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

US Patent 8088799 · Granted Jan 3, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for determining sodium-proton-exchanger ligand efficiency2013
Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation,2013
Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation,2012
Use of PPAR agonists for the treatment of congestive heart failure2009
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropa2009
Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators2008
Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation,2008
Method for screening for activators of soluble guanylate cyclase having oxidized2007
Pyrazole derivatives, their preparation and their use in pharmaceuticals2007
Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use2006
Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use 2006
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropa2005